Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials
Yıl: 2021 Cilt: 29 Sayı: 2 Sayfa Aralığı: 251 - 262 Metin Dili: İngilizce DOI: 10.5152/FNJN.2021.19171 İndeks Tarihi: 02-10-2021
Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials
Öz: AIM: This systematic review aimed to evaluate the efficacy of preventive and therapeutic approaches used in the management of ascites in liver cirrhosis.METHOD: Literature review was done in “Scopus, Web of Science, CINAHL, ScienceDirect, PubMed MEDLINE, Ulakbim National Database, and Cochrane Library” databases using the keywords, “ascites, refractory ascites, liver cirrhosis, intervention, prophylaxis, treatment, nursing management, prevention, ascites management, randomized controlled trials,” and 2,447 articles were obtained. The studies with low bias risk were included. This systematic review was planned by following the recommendations of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement.RESULTS: A total of 11 randomized controlled trials were included. When the included studies were examined, ascites treatment approaches were evaluated in all of the studies; however, preventive approaches were not evaluated. It was found that mannitol, a diuretic drug, helps ascites management by contributing to weight loss, decrease in abdominal circumference, and urinary sodium excretion. The automatic low-flow ascites pump also reduced the need for large-volume paracentesis. There was a decrease in weight and abdominal circumference measurements when band compression was applied to the umbilicus.CONCLUSION: Therapeutic approaches were found to be effective. It was thought that the lack of nursing practices and the prevention of ascites formation in the abdomen was an important deficiency. Randomized controlled trials were recommended for the prevention of abdominal ascites formation and the side effects of treatment on the patient.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık
- Arroyo, V. (2013). A new method for therapeutic paracen-tesis: The automated low flow pump system. Comments in the context of the history of paracentesis. Journal of Hepatol-ogy, 58(5), 850-852. [Crossref]
- Bari, K., Miñano, C., Shea, M., Inayat, I. B., Hashem, H. J., Gilles, H., Heuman, D., & Garcia-Tsao, G. (2012). The combi-nation of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume para-centesis. Clinical Gastroenterology and Hepatology, 10(10), 1169-1175. [Crossref]
- Bellot, P., Welker, M. W., Soriano, G., von Schaewen, M., Ap-penrodt, B., Wiest, R., Whittaker, S., Tzonev, R., Handshiev, S., Verslype, C., Moench, C., Zeuzem, S., Sauerbruch, T., Guarner, C., Schott, E., Johnson, N., Petrov, A., Katzarov, K., Nevens, F., ... Such, J. (2013). Automated low flow pump system for the treatment of refractory ascites: A multi-center safety and ef-ficacy study. Journal of Hepatology, 58, 5, 922-927. [Crossref]
- Bernardi, M., Caraceni, P., Navickis, R. J., & Wilkes, M. M. (2012). Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials. Hepatol-ogy,55(4), 1172-1181. [Crossref]
- Biecker, E. (2011). Diagnosis and therapy of ascites in liv-er cirrhosis. World Journal of Gastroenterology, 17(10), 1237-1248. [Crossref]
- Bulechek, G. M., Butcher, H. K., Dochterman, J. M., & Wag-ner, C. M., 2017. Nursing Interventions Classification (NIC). (Eds: Erdemir, F., Kav, S., Akman Yılmaz, A.). Istanbul, Turkey: Nobel Medical Bookstores, pp:337-339.
- Bureau, C., Adebayo, D., de Rieu, M. C., Elkrief, L., Valla, D., Peck-Radosavljevic, M., McCune, A., Vargas, V., Simon-Talero, M., Cordoba, J., Angeli, P., Rosi, S., MacDonald, S., Malago, M., Stepanova, M., Younossi, Z.M., Trepte, C., Watson, R., Borisen-ko, O., ... Jalan, R. (2017a). Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter random-ized controlled study. Journal of Hepatology, 67(5), 940-949. [Crossref]
- Bureau, C., Thabut, D., Oberti, F., Dharancy, S., Carbonell, N., Bouvier, A., Mathurin, P., Otal, P., Cabarrou, P., Péron, J.M., & Vinel, J.P. (2017b). Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenter-ology, 152(1), 157-163. [Crossref]
- Caraceni, P., Riggio, O., Angeli, P., Alessandria, C., Neri, S., Foschi, F.G., Levantesi, F., Airoldi, A., Boccia, S., Svegliati-Bar-oni, G., Fagiuoli, S., Romanelli, R.G., Cozzolongo, R., Di Mar-co, V., Sangiovanni, V., Morisco, F., Toniutto, P., Tortora, A., De Marco, R., G., ... Bernardi, M. (2018). Long-term albumin administration in decompensated cirrhosis (ANSWER): An open-label randomised trial. The Lancet, 391(10138), 2417-2429. [Crossref]
- Carpenito-Moyet, L. (2005). Nursing Diagnostics Hand-book (Ed. Erdemir, F.). Istanbul, Turkey: Nobel Medical Book-stores, pp:335-342.
- Cox-North, P., Doorenbus, A., Shannon, S. E., Scott, J., & Curtis, J. R. (2013). The transition to end-of-life care in end-stage liver disease. Journal of Hospice and Palliative Nursing,15(4), 209-215. [Crossref]
- European Association for the Study of the Liver (EASL), (2010). EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 53(3), 397-417.
- European Association for the Study of the Liver (EASL), (2018). EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. Journal of Hepatol-ogy, 69(2), 406-460. [Crossref]
- Fabrellas, N., Carol, M., Torrabadella, F., & De Prada, G. (2018). Nursing care of patients with chronic liver diseases: Time for action. Journal of Advanced Nursing,74, 498-500. [Crossref]
- Fitzpatric, E., (2010). Assessment and management of pa-tients with hepatic disorders. In S. Smeltzer, B. Bare (Eds.), Brunner&Suddarth’s Textbook of Medical Surgical Nursing (pp. 1153-1158). China: Wolters Kluver.
- Fullwood, D., & Purushothaman, A. (2014). Managing asci-tes in patients with chronic liver disease. Nursing Standard, 28(23), 51-58. [Crossref]
- Gimenes, F. R. E., Motta, A. P. G., Silva, P. C. S., Gobbo, A. F. F., Atila, E., & Carvalho, E. C. (2017). Identifying nursing inter-ventions associated with the accuracy used nursing diagnoses for patients with liver cirrhosis. Revista Latino-Americana de Enfermagem,25, e2933. [Crossref]
- Ginès, P., Uriz, J., Calahorra, B., Garcia–Tsao, G., Kamath, P. S., Del Arbol, L. R., Planas, R., Bosch, J., Arroyo, V., & Rodés J. (2002). Transjugular intrahepatic portosystemic shunting ver-sus paracentesis plus albumin for refractory ascites in cirrho-sis. Gastroenterology, 123(6), 1839-1847. [Crossref]
- Hampel, H., Bynum, G. D., Zamora, E., & El-Serag, H. B. (2001). Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. American Journal of Gastroenterology,96(7), 2206-2010. [Crossref]
- Hanafy, A. S., & Hassaneen, A. M. (2016). Rifaximin and midodrine improve clinical outcome in refractory ascites in-cluding renal function, weight loss, and short-term survival. European Journal of Gastroenterology & Hepatology, 28(12), 1455-1461. [Crossref]
- Higgins, J. P. T., Altman, G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., & Sterne, J. A. C. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 343, d5928. [Crossref]
- Liang, J., Zhang, H., Zhao, C., Wang, D., Ma, X., Zhao, S, Wang, S., Niu, L., & Sun, L. (2017). Effects of allogeneic mesenchy-mal stem cell transplantation in the treatment of liver cirrho-sis caused by autoimmune diseases. International Journal of Rheumatic Diseases, 20, 1219-1226. [Crossref]
- Moher, D., Shamseer, L., & Clarke, M. (2015). Preferred re-porting items for systematic review and meta-analysis proto-cols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1. [Crossref]
- Moore, K.P., Wong, F., Gines, P, Bernardi, M., Ochs, A., Saler-no, F., Angeli, P., Porayko, M., Moreau, R., Garcia-Tsao, G., Jimenez, W., Planas, R., & Arroyo, V. (2003). The management of ascites in cirrhosis: Report on the consensus conference of the International Ascites Club. Hepatology,38, 258-266. [Crossref]
- Narahara, Y., Kanazawa, H., Fukuda, T., Matsushita, Y., Harimoto, H., Kidokoro, H., Katakura, T., Atsukawa, M., Taki, Y., Kimura, Y., Nakatsuka, K., & Sakamoto, C. (2011). Tran-sjugular intrahepatic portosystemic shunt versus paracen-tesis plus albumin in patients with refractory ascites who have good hepatic and renal function: A prospective ran-domized trial. Journal of Gastroenterology, 46(1), 78-85. [Crossref]
- Patel, R., Poddar, P., Choksi, D., Pandey, V., Ingle, M., Khairnar, H., & Sawant, P. (2019). Predictors of 1-month and 3-months hospital readmissions in decompensated cirrhosis: A prospec-tive study in a large Asian cohort. Annals of Hepatology, 18(1), 30-39. [Crossref]
- Raza, M. A., Qureshi, U. F., Humayoun, M. A., Waseem, T., & Akram, J. (2011). Effect of intravenous mannitol in mobiliza-tion of resistant cirrhotic ascites. European Journal of Gastro-enterology & Hepatology, 23(2), 184-188. [Crossref]
- Rössle, M., & Gerbes, A. L. (2010). TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydro-thorax: A critical update. Gut, 59, 988-1000. [Crossref]
- Rössle, M., Ochs, A., Gülberg, V., Siegerstetter, V., Holl, J., Deibert, P., Olschewski, M., Reiser, M., & Gerbes, A. L. (2000). A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. New England Journal of Medicine, 342(23), 1701-1707. [Crossref]
- Shah, H. A., & Abu-Amara, M. (2013). Education provides significant benefits to patients with hepatitis B virus or hepa-titis C virus infection: A systematic review. Clinical Gastroen-terology andHepatology,11, 922-933. [Crossref]
- Shaheen, A. A., Nguyen, H. H., Congly, S. E., Kaplan, G. G., & Swain, M. G. (2019). Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver International, 39(5), 878-884. [Crossref]
- Stirnimann, G., Banz, V., Storni, F., & De Gottardi, A. (2017). Automated low-flow ascites pump for the treatment of cir-rhotic patients with refractory ascites. Therapeutic Advances in Gastroenterology, 10(2), 283-292. [Crossref]
- Tapper, E. B., Halbert, B., & Mellinger, J. (2016). Rates of and reasons for hospital readmissions in patients with cirrhosis: A multistate population-based cohort study. Clinical Gastroen-terology and Hepatology, 14(8), 1181-1188. [Crossref]
- Tapper, E. B., & Volk, M. (2017). Strategies to reduce 30-day readmissions in patients with cirrhosis. Current Gastroenter-ology Reports, 19(1), 1. [Crossref]
- The Joanna Briggs Institute, (2014). Chapter eight; The protocol design for reviews of economic evidence, inclusion criteria. InThe Joanna Briggs Institute Reviwers’ Manual: 2014 edition (pp. 88-91). Australia: The Joanna Briggs Institute.
- Thomson, M., Volk, M., Kim, H. M., & Piette, J. D. (2015). An automated telephone monitoring system to identify patients with cirrhosis at risk of re-hospitalization. Digestive Diseases and Sciences,60(12), 3563-3569. [Crossref]
- Volk, M. L., Fisher, N., & Fontana, R. J. (2013). Patient knowl-edge about disease self-management in cirrhosis.The Ameri-can Journal of Gastroenterology,108(3), 302. [Crossref]
- Volk, M. L., Tocco, R. S., Bazick. J., Rakoski, M. O., & Lok, A. S. (2012). Hospital readmissions among patients with decom-pensated cirrhosis. American Journal of Gastroenterology, 107(2), 247-252. [Crossref]
- Werner, K. T., & Perez, S. T. (2012). Role of nurse practi-tioners in the management of cirrhotic patients. The Journal for Nurse Practitioners,8(10), 816-821. [Crossref]
- Wong, F., Gines, P., Watson, H., Horsmans, Y., Angeli, P., Gow, P., Wong, F., Gines, P., Watson, H., Horsmans, Y., Angeli, P., Gow, P., Minini, P., & Bernardi, M. (2010). Effects of a se-lective vasopressin V2 receptor antagonist, satavaptan, on as-cites recurrence after paracentesis in patients with cirrhosis. Journal of Hepatology, 53(2), 283-290. [Crossref]
- Xing, F., Tan, Y., Yan, G. J., Zhang, J. J., Shi, Z. H., Tan, S. Z., Feng, N. P., & Liu, C. H. (2012). Effects of Chinese herbal cat-aplasm Xiaozhang Tie on cirrhotic ascites. Journal of Ethno-pharmacology, 139(2), 343-349. [Crossref]
- Zhao, R., Lu, J., Shi, Y., Zhao, H., Xu, K., & Sheng, J. (2018). Current management of refractory ascites in patients with cirrhosis. Journal of International ical Research, 46(3), 1138-1145. [Crossref].
| APA | CELIK F, Bektas H (2021). Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. , 251 - 262. 10.5152/FNJN.2021.19171 |
| Chicago | CELIK Ferya,Bektas Hicran Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. (2021): 251 - 262. 10.5152/FNJN.2021.19171 |
| MLA | CELIK Ferya,Bektas Hicran Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. , 2021, ss.251 - 262. 10.5152/FNJN.2021.19171 |
| AMA | CELIK F,Bektas H Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. . 2021; 251 - 262. 10.5152/FNJN.2021.19171 |
| Vancouver | CELIK F,Bektas H Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. . 2021; 251 - 262. 10.5152/FNJN.2021.19171 |
| IEEE | CELIK F,Bektas H "Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials." , ss.251 - 262, 2021. 10.5152/FNJN.2021.19171 |
| ISNAD | CELIK, Ferya - Bektas, Hicran. "Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials". (2021), 251-262. https://doi.org/10.5152/FNJN.2021.19171 |
| APA | CELIK F, Bektas H (2021). Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale journal of nursing (Online), 29(2), 251 - 262. 10.5152/FNJN.2021.19171 |
| Chicago | CELIK Ferya,Bektas Hicran Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale journal of nursing (Online) 29, no.2 (2021): 251 - 262. 10.5152/FNJN.2021.19171 |
| MLA | CELIK Ferya,Bektas Hicran Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale journal of nursing (Online), vol.29, no.2, 2021, ss.251 - 262. 10.5152/FNJN.2021.19171 |
| AMA | CELIK F,Bektas H Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale journal of nursing (Online). 2021; 29(2): 251 - 262. 10.5152/FNJN.2021.19171 |
| Vancouver | CELIK F,Bektas H Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale journal of nursing (Online). 2021; 29(2): 251 - 262. 10.5152/FNJN.2021.19171 |
| IEEE | CELIK F,Bektas H "Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials." Florence Nightingale journal of nursing (Online), 29, ss.251 - 262, 2021. 10.5152/FNJN.2021.19171 |
| ISNAD | CELIK, Ferya - Bektas, Hicran. "Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials". Florence Nightingale journal of nursing (Online) 29/2 (2021), 251-262. https://doi.org/10.5152/FNJN.2021.19171 |
